INNATE PHARMA SA (IPHA): Price and Financial Metrics
IPHA Price/Volume Stats
| Current price | $2.15 | 52-week high | $3.51 |
| Prev. close | $2.14 | 52-week low | $1.29 |
| Day low | $2.02 | Volume | 13,600 |
| Day high | $2.21 | Avg. volume | 149,401 |
| 50-day MA | $2.06 | Dividend yield | N/A |
| 200-day MA | $2.00 | Market Cap | 198.18M |
IPHA Stock Price Chart Interactive Chart >
INNATE PHARMA SA (IPHA) Company Bio
Innate Pharma SA is a biopharmaceutical company, which focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. Its products include immunotherapy drugs and monoclonal antibodies. The Immunotherapy drugs are designated for cancer and inflammatory diseases. The Monoclonal antibodies targets receptors and pathways controlling the activation of innate immunity cells.
IPHA Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
IPHA Price Returns
| 1-mo | -9.49% |
| 3-mo | 0.94% |
| 6-mo | 46.26% |
| 1-year | -19.17% |
| 3-year | -28.81% |
| 5-year | -65.71% |
| YTD | 16.85% |
| 2024 | -34.29% |
| 2023 | -24.93% |
| 2022 | -18.20% |
| 2021 | 11.49% |
| 2020 | -36.49% |